• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Should I consider Ipsen?

Should I consider Ipsen?

  • yes

    Votes: 0 0.0%
  • RUN!

    Votes: 0 0.0%

  • Total voters
    0
4 years with Ipsen Oncology. 2 excellent medications. ONIVYDE is standard of care 2L post Gem and is the only NCCN CAT. 1 in the space. More indications on the horizon. SD is superior to alternative and continues to grow. There will be generic for LAR in the near future. Base pay is north of 150K and the back of the pack makes at least 8k paid quarterly. I’ve had years of 30K per quarter payouts. Fantastic company trips, highly supportive leadership and very agile. Unfortunately as with all great things we r starting to adopt)slowly) some big Pharm BS. As with all companies, your direct manager plays an important role in your happiness. I am optimistic that we will continue to be a great place to call home. Benefits are excellent. Nissan Pathfinder/Murano or Jeep Laredo or hybrid Toyota SUV are the vehicle options. Good luck


I applied for this oncology position. I received an email that said recruitment would reach out. Any insight on how I can nail this interview or job?